LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

Home・Elenco Azioni・CorMedix Inc

CorMedix Inc

Chiusa

SettoreSettore sanitario

13.02 2.28

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

12.75

Massimo

13.82

Metriche Chiave
By Trading Economics
Entrata	40B 40B
Vendite	655K 40M
P/E Media del settore	16.346 35.664
EPS	0.28
Margine di Profitto	101,797.944
Dipendenti	64
EBITDA	-297K 21M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+60.78% upside

Dividendi
By Dow Jones
Utili prossimi	29 ott 2025

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	31M 952M
Apertura precedente	10.74
Chiusura precedente	13.02

Notizie sul Sentiment di mercato

By Acuity

21%

79%

46 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

9.2 / N/A Supporto e resistenza

CorMedix Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 set 2025, 23:37 UTC

Azioni calde

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 set 2025, 20:41 UTC

Utili

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 set 2025, 20:30 UTC

Utili

GameStop 2Q Sales, Profit Rise

9 set 2025, 23:19 UTC

Discorsi di Mercato

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 set 2025, 21:35 UTC

Utili

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 set 2025, 21:32 UTC

Utili

Oracle's Backlog Swells With Big Customer Deals -- Update

9 set 2025, 21:02 UTC

Acquisizioni, Fusioni, Takeovers

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

9 set 2025, 20:33 UTC

Utili

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 set 2025, 20:26 UTC

Utili

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 set 2025, 20:23 UTC

Utili

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 set 2025, 20:12 UTC

Utili

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 set 2025, 20:10 UTC

Utili

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 set 2025, 20:10 UTC

Utili

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 set 2025, 20:09 UTC

Utili

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 set 2025, 20:09 UTC

Utili

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 set 2025, 20:08 UTC

Utili

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 set 2025, 20:08 UTC

Utili

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 set 2025, 20:08 UTC

Utili

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 set 2025, 20:08 UTC

Utili

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 set 2025, 20:07 UTC

Utili

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 set 2025, 20:06 UTC

Utili

Oracle 1Q Software Revenue $5.72B >ORCL

9 set 2025, 20:06 UTC

Utili

Synopsys 3Q Adj EPS $3.39 >SNPS

9 set 2025, 20:06 UTC

Utili

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 set 2025, 20:05 UTC

Utili

Oracle 1Q Rev $14.93B >ORCL

9 set 2025, 20:05 UTC

Utili

Oracle 1Q EPS $1.01 >ORCL

9 set 2025, 20:05 UTC

Utili

Synopsys 3Q EPS $1.50 >SNPS

9 set 2025, 20:05 UTC

Utili

Oracle 1Q Services Revenue $1.35B >ORCL

9 set 2025, 20:05 UTC

Utili

Oracle 1Q Adj EPS $1.47 >ORCL

9 set 2025, 20:05 UTC

Utili

Oracle 1Q Hardware Revenue $670M >ORCL

Confronto tra pari

Modifica del prezzo

CorMedix Inc Previsione

Obiettivo di Prezzo

By TipRanks

60.78% in crescita

Previsioni per 12 mesi

Media 20.5 USD 60.78%

Alto 23 USD

Basso 17 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per CorMedix Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

7 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 7 che hanno fornito valutazioni azionarie a CorMedix Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

9.2 / N/ASupporto e resistenza

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

46 / 371 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.